The Food and Drug Administration Food Safety Modernization Act: Prevention-Oriented Import System Regulations and Implementation; Public Meeting, 9761-9763 [2016-04127]
Download as PDF
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Rules and Regulations
(3) For service information identified in
this AD, contact Boeing Commercial
Airplanes, Attention: Data & Services
Management, P. O. Box 3707, MC 2H–65,
Seattle, WA 98124–2207; telephone 206–
544–5000, extension 1; fax 206–766–5680;
Internet https://www.myboeingfleet.com.
(4) You may view this service information
at FAA, Transport Airplane Directorate, 1601
Lind Avenue SW., Renton, WA. For
information on the availability of this
material at the FAA, call 425–227–1221.
(5) You may view this service information
that is incorporated by reference at the
National Archives and Records
Administration (NARA). For information on
the availability of this material at NARA, call
202–741–6030, or go to: https://
www.archives.gov/federal-register/cfr/ibrlocations.html.
Issued in Renton, Washington, on February
8, 2016.
Michael Kaszycki,
Acting Manager, Transport Airplane
Directorate, Aircraft Certification Service.
[FR Doc. 2016–03459 Filed 2–25–16; 8:45 am]
BILLING CODE 4910–13–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 1, 11, 16, and 111
[Docket No. FDA–2015–N–0797]
RIN 0910–AG64 and 0910–AG66
The Food and Drug Administration
Food Safety Modernization Act:
Prevention-Oriented Import System
Regulations and Implementation;
Public Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notification of public meeting.
The Food and Drug
Administration (FDA or we) is
announcing a public meeting entitled
‘‘FDA Food Safety Modernization Act:
Prevention-Oriented Import System
Regulations and Implementation.’’ The
public meeting will provide importers
and other interested persons an
opportunity to discuss import safety
regulations and programs, including
final rules for foreign supplier
verification programs (FSVPs) for
importers of food for humans and
animals (the FSVP final rule) and
accreditation of third-party certification
bodies (the third-party certification final
rule). Participants will also be briefed
on the status of FDA’s Voluntary
Qualified Importer Program (VQIP),
which is still in development.
Additionally, the public meeting will
provide importers and other interested
mstockstill on DSK4VPTVN1PROD with RULES
SUMMARY:
VerDate Sep<11>2014
17:33 Feb 25, 2016
Jkt 238001
persons an opportunity to discuss FDA’s
comprehensive planning effort for the
next phase of the FDA Food Safety
Modernization Act implementation
relating to import safety programs,
which includes establishing the
operational framework for these
programs and plans for guidance
documents, training, education, and
technical assistance.
DATES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document for dates and times of the
public meeting, closing dates for
advance registration, and requesting
special accommodations due to
disability.
ADDRESSES: See section III, ‘‘How to
Participate in the Public Meeting’’ in the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT: For
questions about registering for the
meeting, or to register by phone:
Courtney Treece, Planning Professionals
Ltd., 1210 West McDermott St., Suite
111, Allen, TX 75013, 704–258–4983,
FAX: 469–854–6992, email: ctreece@
planningprofessionals.com.
For general questions about the
meeting or for special accommodations
due to a disability: Juanita Yates, Center
for Food Safety and Applied Nutrition
(HFS–009), Food and Drug
Administration, 5100 Paint Branch
Pkwy., College Park, MD 20740, 240–
402–1731, email: Juanita.yates@
fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization
Act (FSMA) (Pub. L.111–353), signed
into law by President Obama on January
4, 2011, enables FDA to better protect
public health by helping to ensure the
safety and security of the food supply.
FSMA amends the Federal Food, Drug,
and Cosmetic Act (the FD&C Act) to
establish the foundation of a
modernized, prevention-based food
safety system. Among other things,
FSMA directs FDA to issue regulations
requiring preventive controls for human
food and animal food, setting standards
for produce safety, and requiring
importers to perform certain activities to
help ensure that the food they bring into
the United States is produced in a
manner consistent with U.S. safety
standards.
In the Federal Register of November
27, 2015, we published the FSVP final
rule (80 FR 74225) and the third-party
certification final rule (80 FR 74569).
The FSVP final rule requires
importers of food to verify that their
PO 00000
Frm 00021
Fmt 4700
Sfmt 4700
9761
foreign suppliers use processes and
procedures that provide the same level
of public health protection as the
preventive controls and produce safety
regulations, where applicable, and also
to verify that the food they import is not
adulterated and is not misbranded with
respect to food allergen labeling.
The third-party certification final rule
adopts regulations to provide for
accreditation of third-party certification
bodies to conduct food safety audits of
foreign entities, including registered
foreign food facilities, and to issue food
and facility certifications under FSMA.
Certification will be required to
establish VQIP eligibility. To prevent
potentially harmful food from reaching
U.S. consumers, in specific
circumstances FDA also may require a
food offered for import to be
accompanied by a certification.
On June 5, 2015, we published a
notice of availability of a draft guidance
for industry on VQIP for importers of
human or animal food (80 FR 32136).
The draft guidance describes and
answers questions about VQIP. To
ensure that we consider comments on
the draft guidance before we complete a
final version of the guidance, we invited
electronic or written comments on the
draft guidance by August 19, 2015.
The FSVP and third-party
certification final rules and related fact
sheets are available on FDA’s FSMA
Web page located at https://www.fda.gov/
FSMA.
The FSVP and third-party
certification final rules are two of
several final rules that will establish the
foundation of, and central framework
for, the modern food safety system
envisioned by Congress in FSMA.
II. Purpose and Format of the Public
Meeting
FDA is holding the public meeting on
FSMA’s prevention-oriented import
system to brief participants on the key
components of the FSVP and third-party
certification final rules; brief
participants on the status of the VQIP;
discuss the plans for guidance
documents related to import safety, as
well as training, education, and
technical assistance; provide an update
on the development of a risk-based
industry oversight framework that are at
the core of FSMA; and answer questions
about these import programs.
The public meeting is an opportunity
for FDA to share its current thinking on
implementation plans for programs
related to import safety. We encourage
interested persons to provide feedback
during the meeting on any ideas that we
present at the public meeting related to
the operational aspects of FSMA
E:\FR\FM\26FER1.SGM
26FER1
9762
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Rules and Regulations
implementation. The agenda and other
documents will be accessible on our
FSMA Web site at https://www.fda.gov/
FSMA before the public meeting.
There will be an opportunity for
stakeholders who are unable to
participate in person to join the meeting
via Webcast. (See section III for more
information on the Webcast option.)
Following the public meeting, FDA
plans to continue dialogue on
implementation of these import safety
programs with a series of regional
meetings across the United States.
III. How To Participate in the Public
Meeting
We are holding the public meeting on
March 21, 2016, from 8:30 a.m. until 5
p.m., at FDA’s Center for Food Safety
and Applied Nutrition, Wiley
Auditorium, 5100 Paint Branch
Parkway, College Park, MD 20740. Due
to limited space and time, we encourage
all persons who wish to attend the
meeting to register in advance. There is
no fee to register for the public meeting,
and registration will be on a first-come,
first-served basis. Early registration is
recommended because seating is
limited. Onsite registration will be
accepted, as space permits, after all
preregistered attendees are seated.
Those requesting an opportunity to
make an oral presentation during the
time allotted for public comment at the
meeting are asked to focus their remarks
on the implementation or operational
aspects of the import safety programs.
To make such a presentation, please
submit a request and provide the
specific topic or issue to be addressed.
Due to the anticipated high level of
interest in presenting public comment
and the limited time available, we are
allocating 3 minutes to each speaker to
make an oral presentation. Speakers will
be limited to making oral remarks; there
will not be an opportunity to display
materials such as slide shows, videos, or
other media during the meeting. If time
permits, individuals or organizations
that did not register in advance may be
granted the opportunity to make an oral
presentation. We would like to
maximize the number of individuals
who make a presentation at the meeting
and will do our best to accommodate all
persons who wish to make a
presentation or express their opinions at
the meeting.
We encourage persons and groups
who have similar interests to
consolidate their information for
presentation by a single representative.
After reviewing the presentation
requests, we will notify each participant
before the meeting of the approximate
time their presentation is scheduled to
begin, and remind them of the
presentation format (i.e., 3-minute oral
presentation without visual media).
We encourage interested persons to
provide feedback on any ideas that we
present at the public meeting related to
the operational aspects of FSMA
implementation.
Table 1 provides information on
participation in the public meeting.
TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING
Date
March 21, 2016,
from 8:30 a.m.
to 5 p.m. ET.
View Webcast ........
March 21, 2016,
from 8:30 a.m.
to 5 p.m. ET.
Preregister .............
Register by March
14, 2016.
Request to make a
public comment.
Request by March
7, 2016.
Request special accommodations
due to a disability
Submit electronic
questions about
the FSMA final
rules.
mstockstill on DSK4VPTVN1PROD with RULES
Attend public meeting.
Request by March
7, 2016.
...............................
Electronic address
Address
Other Information
Please
preregister
at
https://
www.fda.gov/Food/NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Individuals who wish to participate by
Webcast are asked to preregister at
https://www.fda.gov/Food/
NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Individuals who wish to participate in
person are asked to preregister at
https://www.fda.gov/Food/
NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Individuals who wish to make a public
comment during the Open Public
Comment and Q&A Session are
asked to submit request at https://
www.fda.gov/Food/NewsEvents/
WorkshopsMeetingsConferences/
default.htm.
Juanita Yates, email: Juanita.yates@
fda.hhs.gov.
FDA Center for Food Safety and Applied Nutrition, Wiley Auditorium,
5100 Paint Branch Parkway, College Park, MD 20740.
..............................................................
Registration checkin begins at 8
a.m.
Submit questions to the FDA FSMA
Technical Assistance Network at
https://www.fda.gov/Food/
GuidanceRegulation/FSMA/
ucm459719.htm.
..............................................................
We encourage the use of electronic
registration, if possible1.
The Webcast will
have closed captioning.
There is no registration fee for
the public meeting.
..............................................................
See FOR FURTHER INFORMATION
CONTACT.
For more information about the
FDA FSMA
Technical Assistance Network,
visit https://
www.fda.gov/
Food/
GuidanceRegulation/FSMA/
ucm459719.htm.
1 You may also register via email, mail, or fax. Please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals Ltd., 1210 West McDermott St., Suite 111, Allen, TX 75013, 704–
258–4983, FAX: 469–854–6992, email: ctreece@planningprofessionals.com.
VerDate Sep<11>2014
17:33 Feb 25, 2016
Jkt 238001
PO 00000
Frm 00022
Fmt 4700
Sfmt 4700
E:\FR\FM\26FER1.SGM
26FER1
Federal Register / Vol. 81, No. 38 / Friday, February 26, 2016 / Rules and Regulations
IV. Transcripts and Recorded Video
Please be advised that as soon as a
transcript is available, it will be
accessible at
https://www.regulations.gov and at
FDA’s FSMA Web site at: https://
www.fda.gov/FSMA. You may also view
the transcript at the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, Rm.
1061, Rockville, MD 20852. A transcript
will also be available in either hardcopy
or on CD–ROM, after submission of a
Freedom of Information request. The
Freedom of Information office address is
available on FDA’s Web site at https://
www.fda.gov. Additionally, we will be
video recording the public meeting.
Once the recorded video is available, it
will be accessible at FDA’s FSMA Web
site at https://www.fda.gov/FSMA.
Dated: February 23, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016–04127 Filed 2–25–16; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
21 CFR Part 1301
[Docket No. DEA–394F]
RIN 1117–AB38
Removal of Exemption From
Registration for Persons Authorized
Under U.S. Nuclear Regulatory
Commission or Agreement State
Medical Use Licenses or Permits and
Administering the Drug Product
DaTscan
Drug Enforcement
Administration, Department of Justice.
ACTION: Final rule.
AGENCY:
On November 25, 2014, the
Drug Enforcement Administration
published the interim final rule titled
‘‘Exemption from Registration for
Persons Authorized Under U.S. Nuclear
Regulatory Commission or Agreement
State Medical Use Licenses or Permits
and Administering the Drug Product
DaTscan.’’ The Drug Enforcement
Administration is hereby removing this
interim final rule as it is no longer
needed, as a result of the removal of
[123I]ioflupane from the schedules of
controlled substances effective
September 11, 2015.
DATES: Effective Date: February 26,
2016.
FOR FURTHER INFORMATION CONTACT:
Barbara J. Boockholdt, Office of
mstockstill on DSK4VPTVN1PROD with RULES
SUMMARY:
VerDate Sep<11>2014
17:33 Feb 25, 2016
Jkt 238001
Diversion Control, Drug Enforcement
Administration; Mailing Address: 8701
Morrissette Drive, Springfield, Virginia
22152, Telephone: (202) 598–6812.
SUPPLEMENTARY INFORMATION:
Legal Authority
The Drug Enforcement
Administration (DEA) implements and
enforces Titles II and III of the
Comprehensive Drug Abuse Prevention
and Control Act of 1970, as amended. 21
U.S.C. 801–971. Titles II and III are
referred to as the ‘‘Controlled
Substances Act’’ and the ‘‘Controlled
Substances Import and Export Act,’’
respectively, and are collectively
referred to as the ‘‘Controlled
Substances Act’’ or the ‘‘CSA’’ for the
purpose of this action. The DEA
publishes the implementing regulations
for these statutes in title 21 of the Code
of Federal Regulations (CFR), chapter II.
The CSA and its implementing
regulations are designed to prevent,
detect, and eliminate the diversion of
controlled substances and listed
chemicals into the illicit market while
providing for the legitimate medical,
scientific, research, and industrial needs
of the United States. Controlled
substances have the potential for abuse
and dependence and are controlled to
protect the public health and safety.
Under the CSA, each controlled
substance is classified into one of five
schedules based upon its potential for
abuse, its currently accepted medical
use in treatment in the United States,
and the degree of dependence the
substance may cause. 21 U.S.C. 812. The
initial schedules of controlled
substances established by Congress are
found at 21 U.S.C. 812(c), and pursuant
to 21 U.S.C. 812 (a) and (b), the current
list of all scheduled substances is
published at 21 CFR part 1308.
Pursuant to 21 U.S.C. 822(a)(1), every
person who manufactures or distributes
any controlled substance or list I
chemical, or who proposes to engage in
the manufacture or distribution of any
controlled substance or list I chemical,
shall obtain annually a registration
issued by the Attorney General in
accordance with the rules and
regulations promulgated by the Attorney
General. Further, pursuant to 21 U.S.C.
822(a)(2), every person who dispenses,
or who proposes to dispense, any
controlled substance, shall obtain from
the Attorney General a registration
issued in accordance with the rules and
regulations promulgated by the Attorney
General.
The Attorney General however may,
by regulation, waive the requirement for
registration of certain manufacturers,
distributors, or dispensers if the
PO 00000
Frm 00023
Fmt 4700
Sfmt 4700
9763
Attorney General finds it consistent
with the public health and safety
pursuant to 21 U.S.C. 822(d). The
Attorney General delegated this
authority to the Administrator of the
DEA, 28 CFR 0.100(b), who in turn
redelegated that authority to the Deputy
Assistant Administrator of the DEA
Office of Diversion Control (‘‘Deputy
Assistant Administrator’’). 28 CFR part
0, subpart R, App. section 7.
Background
On November 25, 2014, the DEA
published an interim final rule (IFR)
exempting from registration persons
authorized under Nuclear Regulatory
Commission (NRC) or Agreement State
Medical Use Licenses or permits and
administering the drug product DaTscan
directly to patients for diagnostic
purposes. 79 FR 70085. The IFR was
intended to alleviate the regulatory
burdens on those administering the drug
product DaTscan, to allow more patients
to receive important diagnostic testing.
Additionally, because persons who
administer DaTscan are subject to strict
NRC/Agreement State requirements, the
DEA determined in the IFR that the
waiver from registration of persons who
administer DaTscan was consistent with
the public health and safety. The IFR
provided an opportunity for interested
persons to submit written comments on
the rulemaking on or before January 26,
2015.
However, effective September 11,
2015, the DEA removed [123I]ioflupane
from the schedules of controlled
substances. 80 FR 54715. [123I]Ioflupane
is the active pharmaceutical ingredient
in DaTscan. Accordingly, a registration
exemption is no longer necessary for
persons who administer the drug
product DaTscan. As the DEA explained
in the final rule removing
[123I]ioflupane from the schedules of
controlled substances, all of the
administrative, civil, and criminal
sanctions applicable to controlled
substances no longer apply to those
persons who handle [123I]ioflupane, or
any drug products that contain
[123I]ioflupane, on or after September
11, 2015.
Because the decontrol of
[123I]ioflupane supersedes the
registration exemption provided in the
IFR, the DEA hereby finalizes the
rulemaking procedure that was initiated
with the November 25, 2014, IFR (79 FR
70085) by publishing this final rule
removing that regulation. Below the
DEA has provided a discussion of
comments received in response to the
IFR. 79 FR 70085.
E:\FR\FM\26FER1.SGM
26FER1
Agencies
[Federal Register Volume 81, Number 38 (Friday, February 26, 2016)]
[Rules and Regulations]
[Pages 9761-9763]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-04127]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Parts 1, 11, 16, and 111
[Docket No. FDA-2015-N-0797]
RIN 0910-AG64 and 0910-AG66
The Food and Drug Administration Food Safety Modernization Act:
Prevention-Oriented Import System Regulations and Implementation;
Public Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notification of public meeting.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA or we) is announcing a
public meeting entitled ``FDA Food Safety Modernization Act:
Prevention-Oriented Import System Regulations and Implementation.'' The
public meeting will provide importers and other interested persons an
opportunity to discuss import safety regulations and programs,
including final rules for foreign supplier verification programs
(FSVPs) for importers of food for humans and animals (the FSVP final
rule) and accreditation of third-party certification bodies (the third-
party certification final rule). Participants will also be briefed on
the status of FDA's Voluntary Qualified Importer Program (VQIP), which
is still in development. Additionally, the public meeting will provide
importers and other interested persons an opportunity to discuss FDA's
comprehensive planning effort for the next phase of the FDA Food Safety
Modernization Act implementation relating to import safety programs,
which includes establishing the operational framework for these
programs and plans for guidance documents, training, education, and
technical assistance.
DATES: See section III, ``How to Participate in the Public Meeting'' in
the SUPPLEMENTARY INFORMATION section of this document for dates and
times of the public meeting, closing dates for advance registration,
and requesting special accommodations due to disability.
ADDRESSES: See section III, ``How to Participate in the Public
Meeting'' in the SUPPLEMENTARY INFORMATION section of this document.
FOR FURTHER INFORMATION CONTACT: For questions about registering for
the meeting, or to register by phone: Courtney Treece, Planning
Professionals Ltd., 1210 West McDermott St., Suite 111, Allen, TX
75013, 704-258-4983, FAX: 469-854-6992, email:
ctreece@planningprofessionals.com.
For general questions about the meeting or for special
accommodations due to a disability: Juanita Yates, Center for Food
Safety and Applied Nutrition (HFS-009), Food and Drug Administration,
5100 Paint Branch Pkwy., College Park, MD 20740, 240-402-1731, email:
Juanita.yates@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
The FDA Food Safety Modernization Act (FSMA) (Pub. L.111-353),
signed into law by President Obama on January 4, 2011, enables FDA to
better protect public health by helping to ensure the safety and
security of the food supply. FSMA amends the Federal Food, Drug, and
Cosmetic Act (the FD&C Act) to establish the foundation of a
modernized, prevention-based food safety system. Among other things,
FSMA directs FDA to issue regulations requiring preventive controls for
human food and animal food, setting standards for produce safety, and
requiring importers to perform certain activities to help ensure that
the food they bring into the United States is produced in a manner
consistent with U.S. safety standards.
In the Federal Register of November 27, 2015, we published the FSVP
final rule (80 FR 74225) and the third-party certification final rule
(80 FR 74569).
The FSVP final rule requires importers of food to verify that their
foreign suppliers use processes and procedures that provide the same
level of public health protection as the preventive controls and
produce safety regulations, where applicable, and also to verify that
the food they import is not adulterated and is not misbranded with
respect to food allergen labeling.
The third-party certification final rule adopts regulations to
provide for accreditation of third-party certification bodies to
conduct food safety audits of foreign entities, including registered
foreign food facilities, and to issue food and facility certifications
under FSMA. Certification will be required to establish VQIP
eligibility. To prevent potentially harmful food from reaching U.S.
consumers, in specific circumstances FDA also may require a food
offered for import to be accompanied by a certification.
On June 5, 2015, we published a notice of availability of a draft
guidance for industry on VQIP for importers of human or animal food (80
FR 32136). The draft guidance describes and answers questions about
VQIP. To ensure that we consider comments on the draft guidance before
we complete a final version of the guidance, we invited electronic or
written comments on the draft guidance by August 19, 2015.
The FSVP and third-party certification final rules and related fact
sheets are available on FDA's FSMA Web page located at https://www.fda.gov/FSMA.
The FSVP and third-party certification final rules are two of
several final rules that will establish the foundation of, and central
framework for, the modern food safety system envisioned by Congress in
FSMA.
II. Purpose and Format of the Public Meeting
FDA is holding the public meeting on FSMA's prevention-oriented
import system to brief participants on the key components of the FSVP
and third-party certification final rules; brief participants on the
status of the VQIP; discuss the plans for guidance documents related to
import safety, as well as training, education, and technical
assistance; provide an update on the development of a risk-based
industry oversight framework that are at the core of FSMA; and answer
questions about these import programs.
The public meeting is an opportunity for FDA to share its current
thinking on implementation plans for programs related to import safety.
We encourage interested persons to provide feedback during the meeting
on any ideas that we present at the public meeting related to the
operational aspects of FSMA
[[Page 9762]]
implementation. The agenda and other documents will be accessible on
our FSMA Web site at https://www.fda.gov/FSMA before the public meeting.
There will be an opportunity for stakeholders who are unable to
participate in person to join the meeting via Webcast. (See section III
for more information on the Webcast option.)
Following the public meeting, FDA plans to continue dialogue on
implementation of these import safety programs with a series of
regional meetings across the United States.
III. How To Participate in the Public Meeting
We are holding the public meeting on March 21, 2016, from 8:30 a.m.
until 5 p.m., at FDA's Center for Food Safety and Applied Nutrition,
Wiley Auditorium, 5100 Paint Branch Parkway, College Park, MD 20740.
Due to limited space and time, we encourage all persons who wish to
attend the meeting to register in advance. There is no fee to register
for the public meeting, and registration will be on a first-come,
first-served basis. Early registration is recommended because seating
is limited. Onsite registration will be accepted, as space permits,
after all preregistered attendees are seated.
Those requesting an opportunity to make an oral presentation during
the time allotted for public comment at the meeting are asked to focus
their remarks on the implementation or operational aspects of the
import safety programs. To make such a presentation, please submit a
request and provide the specific topic or issue to be addressed. Due to
the anticipated high level of interest in presenting public comment and
the limited time available, we are allocating 3 minutes to each speaker
to make an oral presentation. Speakers will be limited to making oral
remarks; there will not be an opportunity to display materials such as
slide shows, videos, or other media during the meeting. If time
permits, individuals or organizations that did not register in advance
may be granted the opportunity to make an oral presentation. We would
like to maximize the number of individuals who make a presentation at
the meeting and will do our best to accommodate all persons who wish to
make a presentation or express their opinions at the meeting.
We encourage persons and groups who have similar interests to
consolidate their information for presentation by a single
representative. After reviewing the presentation requests, we will
notify each participant before the meeting of the approximate time
their presentation is scheduled to begin, and remind them of the
presentation format (i.e., 3-minute oral presentation without visual
media).
We encourage interested persons to provide feedback on any ideas
that we present at the public meeting related to the operational
aspects of FSMA implementation.
Table 1 provides information on participation in the public
meeting.
Table 1--Information on Participation in the Meeting
----------------------------------------------------------------------------------------------------------------
Other
Date Electronic address Address Information
----------------------------------------------------------------------------------------------------------------
Attend public meeting......... March 21, 2016, Please preregister at FDA Center for Food Registration
from 8:30 a.m. https://www.fda.gov/ Safety and Applied check-in begins
to 5 p.m. ET. Food/NewsEvents/ Nutrition, Wiley at 8 a.m.
WorkshopsMeetingsCon Auditorium, 5100
ferences/default.htm. Paint Branch
Parkway, College
Park, MD 20740.
View Webcast.................. March 21, 2016, Individuals who wish ..................... The Webcast will
from 8:30 a.m. to participate by have closed
to 5 p.m. ET. Webcast are asked to captioning.
preregister at https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm.
Preregister................... Register by Individuals who wish We encourage the use There is no
March 14, 2016. to participate in of electronic registration
person are asked to registration, if fee for the
preregister at http:/ possible\1\. public meeting.
/www.fda.gov/Food/
NewsEvents/
WorkshopsMeetingsCon
ferences/default.htm.
Request to make a public Request by March Individuals who wish ..................... ................
comment. 7, 2016. to make a public
comment during the
Open Public Comment
and Q&A Session are
asked to submit
request at https://www.fda.gov/Food/NewsEvents/WorkshopsMeetingsConferences/default.htm.
Request special accommodations Request by March Juanita Yates, email: See FOR FURTHER ................
due to a disability 7, 2016. Juanita.yates@fda.hh INFORMATION CONTACT.
s.gov.
Submit electronic questions ................ Submit questions to ..................... For more
about the FSMA final rules. the FDA FSMA information
Technical Assistance about the FDA
Network at https:// FSMA Technical
www.fda.gov/Food/ Assistance
GuidanceRegulation/ Network, visit
FSMA/ucm459719.htm. https://www.fda.gov/Food/GuidanceRegulation/FSMA/ucm459719.htm.
----------------------------------------------------------------------------------------------------------------
\1\ You may also register via email, mail, or fax. Please include your name, title, firm name, address, and
phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals
Ltd., 1210 West McDermott St., Suite 111, Allen, TX 75013, 704-258-4983, FAX: 469-854-6992, email:
ctreece@planningprofessionals.com.
[[Page 9763]]
IV. Transcripts and Recorded Video
Please be advised that as soon as a transcript is available, it
will be accessible at https://www.regulations.gov and at FDA's FSMA Web
site at: https://www.fda.gov/FSMA. You may also view the transcript at
the Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. A
transcript will also be available in either hardcopy or on CD-ROM,
after submission of a Freedom of Information request. The Freedom of
Information office address is available on FDA's Web site at https://www.fda.gov. Additionally, we will be video recording the public
meeting. Once the recorded video is available, it will be accessible at
FDA's FSMA Web site at https://www.fda.gov/FSMA.
Dated: February 23, 2016.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2016-04127 Filed 2-25-16; 8:45 am]
BILLING CODE 4164-01-P